CLINICAL PREVALENCE OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN ONCO-HEMATOLOGICAL PATIENTS (Atena Editora)

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributor.authorFrigotto, Katia Gleicielly-
Autor(es): dc.contributor.authorGarcia, Giovana Salviano Braga-
Autor(es): dc.contributor.authorValviesse, Vitor Ribeiro Gomes de Almeida-
Autor(es): dc.contributor.authorPires, Karina Lebeis-
Data de aceite: dc.date.accessioned2022-02-25T15:46:14Z-
Data de disponibilização: dc.date.available2022-02-25T15:46:14Z-
Data de envio: dc.date.issued2022-02-20-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/699366-
Resumo: dc.description.abstractBackground: Chemotherapy-Induced Peripheral Neuropathy (CIPN) is a side effect common to many drugs in cancer treatment. CIPN symptoms are mainly sensory, as paresthesia and pain, especially in body extremities. It can affect the patient's life, requiring a dose reduction or interruption of therapy, which can impact patient's survival. Methods: Twenty-one hematology outpatients who were treated by neurotoxic potential drugs were selected. The Douleur neuropathique 4 questionnaire was applied, a patient form was made for data collection, and the data obtained was analyzed. Main Results: The prevalence of CIPN was 47,62%. Five patients (23,81%) did not had signs of neurotoxicity, four (19,05%) patients were classified as Grade 1, seven (33,33% ) as Grade 2, and four (19,05%) as Grade 3, and one (4,76%) patient as Grade 4. Patients who had symptoms of CIPN had already received an average of 55,42% of the scheduled treatment. Three patients (14,29%) had to reduce the dose or change the drugs, and one patient (4,76%) had to discontinue it. Conclusion: This study support the hypothesis that CIPN is an important side effect in cancer treatments. Being a cause of reducing the dose or temporarily suspending it, which can affect the success of the treatment and patient’s survival.pt_BR
Idioma: dc.language.isoenpt_BR
Palavras-chave: dc.subjectCLINICALpt_BR
Título: dc.titleCLINICAL PREVALENCE OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN ONCO-HEMATOLOGICAL PATIENTS (Atena Editora)pt_BR
Tipo de arquivo: dc.typelivro digitalpt_BR
Aparece nas coleções:Livros digitais

Arquivos associados:
CLINICAL.pdf334,55 kBAdobe PDF/bitstream/capes/699366/1/CLINICAL.pdfDownload